Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 321 - 330 of 358

Selected Filters:
1 March 2022

Prevention Options for Women Evaluation Research (POWER) Formative Work Report – August 2017

This is a formative work report on the POWER Study, which aimed to characterize choice, uptake, and early adherence to PrEP, and sought to identify cost-effective and scalable delivery models to young women in Kenya and South Africa.

Research

Document
1 March 2022

Prevention Options for Women Evaluation Research Key Informant Interviews Qualitative Report – July 2020

This is a report on Key Informant Interviews undertaken for the POWER Study, which aimed to characterize choice, uptake, and early adherence to PrEP, and sought to identify cost-effective and scalable delivery models to young women in Kenya and South Africa.

Research

Document
1 February 2022

Digital Health Landscaping Report

This landscape analysis aimed to identify common virtual channels used in several countries, estimate the number of users of each channel, and categorize countries into one of three groups based on potential for interventions to use virtual channels to succeed. Users were defined as adolescent girls and young women (aged 15–24), pregnant or breastfeeding people…

Demand Creation/Marketing, Service Delivery

Document
1 December 2021

Proposed New National-level Indicators for M&E for all forms of PrEP

A series of think tanks brought together PrEP experts to reflect on lessons learned from oral PrEP rollout and how those could applied to provide more meaningful measures of program performance for all forms of PrEP.

Monitoring & Evaluation

Document
25 January 2021

Evaluating, Scaling up and Enhancing Strategies for Supporting PrEP Continuation and Effective Use

The Prevention Product Manager (PMM) a joint partnership between AVAC and the Clinton Health Access Initiative (CHAI) and Jhpiego convened think tanks to discuss options for defining and measuring PrEP continuation. Recommendations from the think tank included modifications to current PrEP indicators, recognizing that a single definition of correct or effective use might not be…

Research, Monitoring & Evaluation, Service Delivery

Document
1 December 2020

PrEP for Pregnant and Breastfeeding People: Implementation Guide (English)

Implementation Guide: Providing PrEP to Pregnant and Breastfeeding People: A Training Manual for Health Care Workers

Normative Guidance/Policies, Service Delivery

Document
24 July 2020

Guidance for the Use of Pre-exposure Prophylaxis (PrEP) for the Prevention of HIV Acquisition in British Columbia

These guidelines were developed by the British Columbia Centre for Excellence in HIV/AIDS and focus on the provision of PrEP as a part of a comprehensive approach to combination prevention, drawing on implementation and research evidence and WHO recommendations.

Normative Guidance/Policies

Document
16 July 2020

South African Guidelines for the Provision of Pre-exposure Prophylaxis (PrEP) to Persons at Substantial Risk of HIV Infection

These guidelines were developed by the South African National Department of Health and focus on the provision of PrEP as a part of a comprehensive approach to combination prevention, drawing on implementation and research evidence and WHO recommendations.

Normative Guidance/Policies

Document
26 May 2020

Oral PrEP Youth Dialogues South Africa

What AGYW really think about PrEP, HIV services and how we talk to them!

Demand Creation/Marketing, Research

Document
10 October 2019

ART Considerations for Individuals with Recent PrEP Use

This brief provides an overview of key findings from modeling the impact of drug resistance with PrEP, conducted by the Global Evaluation of Microbicide Sensitivity (GEMS) project. It is intended to support policymakers as they develop the most appropriate first-line ART treatment recommendations during PrEP rollout.

Service Delivery

Document